Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Veterinary Journal (London, England : 1997)|July 11, 2013
Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trialJ M Quimby, K F LunnThe Journal of Small Animal Practice|April 16, 2025
Clinical characteristics, treatment, and outcomes of hypoadrenocorticism in dogsT N Sherrod, E Lashnits, K F LunnJournal of Neurocytology|May 1, 1997
The temporal progression of the myelination defect in the taiep ratK F Lunn, M K Clayton, I D DuncanJournal of Veterinary Internal Medicine|October 12, 2011
The pharmacokinetics of mirtazapine in cats with chronic kidney disease and in age-matched control catsJ M Quimby, D L Gustafson, K F LunnMicroscopy Research and Technique|October 15, 1995
Myelin mutants: new models and new observationsK F Lunn, M L Fanarraga, I D DuncanThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1997
Microtubule organization and stability in the oligodendrocyteK F Lunn, P W Baas, I D DuncanJournal of Veterinary Internal Medicine|June 26, 2014
Echocardiographic findings in 11 cats with acromegalyJ A Myers, K F Lunn, J M BrightJournal of Veterinary Internal Medicine|March 23, 2011
Variability in results of the microscopic agglutination test in dogs with clinical leptospirosis and dogs vaccinated against leptospirosisM D Miller, K M Annis, M R Lappin, et al.Journal of Veterinary Pharmacology and Therapeutics|October 26, 2010
Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young catsJ M Quimby, D L Gustafson, B J Samber, et al.Journal of Neurocytology|December 1, 1992
The taiep rat: a myelin mutant with an associated oligodendrocyte microtubular defectI D Duncan, K F Lunn, B Holmgren, et al.Pageof 2